2. Academic Validation
  3. The Impact of the FXR1-FUBP1 Axis on Chemotherapy Resistance in LUSC Cells

The Impact of the FXR1-FUBP1 Axis on Chemotherapy Resistance in LUSC Cells

  • Biochem Genet. 2025 Nov 22. doi: 10.1007/s10528-025-11290-1.
Renji Liang 1,  Yuehua Li 2,  Jiayang Chen 1,  Hao Deng 3
Affiliations

Affiliations

  • 1 Department of Cardiocthoracic-Vascular Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, No. 69 Chuanshan Road, Zhengxiang District, Hengyang, 421001, Hunan, China.
  • 2 Department of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.
  • 3 Department of Cardiocthoracic-Vascular Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, No. 69 Chuanshan Road, Zhengxiang District, Hengyang, 421001, Hunan, China. [email protected].
PMID: 41273664 DOI: 10.1007/s10528-025-11290-1
Keywords

Chemotherapy resistance; FUBP1; FXR1; Immune evasion; Lung cancer.

Figures
Products
Inhibitors & Agonists
Other Products